Tassev, D V <br/><br/>
Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.  [electronic resource] 

 -  Cancer gene therapy  Feb 2012 
 - 84-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2011.66  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Viral--immunology<br/>CHO Cells<br/>Cell Line<br/>Chimerism<br/>Cricetinae<br/>Epitopes, T-Lymphocyte--immunology<br/>Epstein-Barr Virus Nuclear Antigens<br/>HLA-A2 Antigen--genetics<br/>Humans<br/>Immunoglobulin Fragments--immunology<br/>Killer Cells, Natural--immunology<br/>Oligopeptides--immunology<br/>Receptors, Antigen--genetics